Compounded Semaglutide and Tirzepatide in California: How to Access GLP-1 Treatment Online

Quick answer: California residents can access compounded semaglutide and compounded tirzepatide through telehealth, with no in-person visit required. Fig serves all 50 states, including California. You complete a free online health assessment, a U.S.-licensed provider reviews your medical history, and medication is prescribed only if it is clinically appropriate for you. Fig's plans start at $145/month* for compounded semaglutide and $258/month* for compounded tirzepatide, with no membership fee and free shipping. Compounded medications are not FDA-approved.

California is the most populous state in the country, with nearly 39 million residents, and it has one of the lower adult obesity rates nationally. According to the Trust for America's Health State of Obesity 2025 report, which analyzes 2024 BRFSS data, 25.8% of California adults have obesity.1 Even at that rate, the sheer size of California's population means that millions of residents are affected.

California expanded Medicaid (Medi-Cal) under the Affordable Care Act, and the state's uninsured rate is relatively low: according to the U.S. Census Bureau's 2024 American Community Survey, 6.4% of California residents are uninsured.2 However, insurance coverage for compounded GLP-1 medications is rare regardless of plan type, and even brand-name GLP-1s like Ozempic and Wegovy require extensive prior authorization. California's high cost of living also makes the price of weight management care a significant consideration. For Californians looking for affordable, accessible GLP-1 treatment, online telehealth programs like Fig offer a transparent, straightforward option.

Start Your Free Assessment →

Can I Get Compounded GLP-1 Medication in California?

Yes. Fig is a telehealth platform that serves all 50 states, including California. Residents of Los Angeles, San Francisco, San Diego, Sacramento, San Jose, Dublin, Soquel, and communities throughout the state can access Fig's program entirely online, with no in-person visit required.

California has one of the most developed telehealth ecosystems in the country, and Fig's asynchronous process is well-suited to the state's busy, mobile population.

What Does Fig Offer California Residents?

Fig offers access to compounded semaglutide and compounded tirzepatide when prescribed by a licensed provider as clinically appropriate. Both medications are prepared by state-licensed, FDA-registered 503A compounding pharmacies in the United States.

Fig's pricing is all-inclusive with no membership fee, no consultation fee, and no shipping charge added at checkout.

Medication Monthly Plan 3-Month Plan 6-Month Plan Compounded Semaglutide $175/mo $165/mo $145/mo Compounded Tirzepatide $279/mo $265/mo $258/mo

In a state where the cost of living is among the highest in the nation, the absence of a mandatory membership fee — which many competing platforms charge at $100 to $149 per month — represents meaningful savings over the course of treatment.

How the Fig Process Works in California

1. Complete Fig's free online health assessment from anywhere in California, covering your medical history, current medications, and weight management goals.

2. A licensed medical provider reviews your information and determines whether treatment is clinically appropriate.

3. If a prescription is issued, pricing is shown transparently before any payment is required.

4. Medication and supplies are shipped discreetly to your California address at no additional shipping cost.

5. Ongoing support is included throughout your treatment experience.

The process is fully asynchronous. There are no scheduled video appointments, and you can complete the intake on your own schedule.

Does Insurance Cover GLP-1 Medication in California?

Most insurance plans in California, including Medi-Cal, do not cover compounded GLP-1 medications. Coverage for brand-name GLP-1s exists in some commercial plans but typically requires prior authorization, a documented diagnosis, and often documented failure of prior weight loss interventions.

Fig does not require insurance to begin. The eligibility process is open to any California resident who meets the clinical criteria.

FSA and HSA funds may be eligible for use toward Fig's plans. Compounded GLP-1 medications prescribed for a diagnosed medical condition generally qualify as a medical expense under IRS guidelines. Check with your plan administrator to confirm.

Frequently Asked Questions

Does Fig ship to all parts of California?

Yes. Fig ships to all California addresses, including Los Angeles, the Bay Area, San Diego, the Central Valley, Sacramento, and rural communities throughout the state.

Do I need a California-licensed doctor to use Fig?

No. Fig's network of licensed providers can evaluate and prescribe for California residents through the telehealth platform.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide is not the same as, nor a substitute for, FDA-approved semaglutide products such as Ozempic or Wegovy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.

Can I use my FSA or HSA card to pay for Fig?

In most cases, yes. Because Fig's pricing is all-inclusive with no separate membership fee, the full cost is typically eligible as a qualified medical expense. Confirm with your FSA or HSA administrator.

Can I cancel anytime?

Yes. Fig offers month-to-month options and patients can cancel anytime, subject to any active orders already in processing.

Getting Started

California residents looking for transparent, affordable access to GLP-1 weight management can start Fig's free eligibility assessment at startfig.com.

Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Fig does not guarantee weight loss results. Individual outcomes vary. Treatment is only prescribed when a licensed provider determines it is clinically appropriate.

Footnotes

1. Trust for America's Health. State of Obesity 2025: Better Policies for a Healthier America. 2024 BRFSS data. https://www.tfah.org/report-details/state-of-obesity-report-2025/ ↩

2. U.S. Census Bureau. Health Insurance Coverage by State: 2023 and 2024. American Community Survey 1-Year Estimates, 2024. https://www2.census.gov/library/publications/2025/demo/acsbr-024.pdf ↩

Keep reading

Comparing providers? Browse the full GLP-1 provider comparison library, or see all guides in the Fig Journal.

Related: How Much Does Semaglutide Cost Without Insurance in 2026?

Also helpful: What is Compounded Semaglutide? Safety, Quality, and What You Need to Know

Wondering whether GLP-1 treatment could be right for you? Take the free assessment to see if you qualify.

Important Safety Information: Common side effects of compounded semaglutide and compounded tirzepatide may include nausea, vomiting, diarrhea, stomach pain, and constipation. Serious side effects may include inflammation of the pancreas (pancreatitis), gallbladder problems, increased risk of low blood sugar (hypoglycemia), kidney problems, and serious allergic reactions. These medications should not be used if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Telehealth Disclosure: Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. A prescription is not guaranteed. Rx required. Not available in all states. The information provided on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Compounding Disclosure: Compounded products are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded semaglutide and compounded tirzepatide are not the same as, nor substitutes for, FDA-approved semaglutide products (Wegovy®, Ozempic®) or tirzepatide products (Mounjaro®, Zepbound®). Compounded medications are not generic drugs. Fig is partnered with state-licensed, FDA-registered 503A compounding pharmacies that prepare all medications.